Population Pharmacokinetic Model of Sublingual Buprenorphine in Neonatal Abstinence Syndrome

OBJECTIVE: Neonatal abstinence syndrome (NAS)—a clinical entity of infants from in utero exposure to psychoactive xenobiotic and buprenorphine—has been successfully used to treat NAS. However, nothing is known about the pharmacokinetics (PK) of buprenorphine in neonates with NAS. To our knowledge, t...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Pharmacotherapy
Main Authors: Ng, Chee M., Dombrowsky, Erin, Lin, Hopi, Erlich, Michelle E., Moody, David E., Barrett, Jeffrey S., Kraft, Walter K.
Format: Artigo
Jezik:Inglês
Izdano: 2015
Teme:
Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC5119858/
https://ncbi.nlm.nih.gov/pubmed/26172282
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/phar.1610
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki